Navigation Links
Meningitis Shot Available, Effective Year-Round

If your kids missed back-to-school crush, they can still get the lifesaving vaccine, experts say

THURSDAY, Oct. 25 (HealthDay News) -- At the beginning of every school year, concerned parents rush to get their kids the meningitis vaccine, with demand sometimes outpacing supply.

It doesn't have to be that way, experts say, since this potentially lifesaving shot is available year-round.

While August and September are fine times to vaccinate, the vaccine can also be gotten earlier or later, the experts note. That's important, they add, since meningitis can strike anytime.

"It's a year-round disease," said Lynn Bozof, executive director of the National Meningitis Association. "It can strike anyone at anytime."

Bozof should know: She lost her son Evan, then 20, to the disease in 1998.

"It actually peaks in the wintertime," added Donna Cary, a spokeswoman for Sanofi Pasteur Inc., of Swiftwater, Penn., the drug company that makes both of the meningitis vaccines currently available in the United States.

Meningococcal disease is a viral or bacterial infection, with the bacterial form being rarer but much more deadly. The disease is spread through air droplets and via direct contact with persons who are infected such as by kissing, sharing drinking glasses or coughing, according to the National Meningitis Association.

Every year in the United States, nearly 3,000 people come down with bacterial meningitis, according to the U.S. Centers for Disease Control and Prevention, and about 10 percent to 12 percent -- or about 300 to 360 cases -- are fatal. Those who survive may have complications such as brain damage or limb amputation.

Bacteria can attach to the nasal mucosal lining and mucosal lining in the throat and multiply there. They can then enter the bloodstream, traveling rapidly and causing organ damage.

Meningococcal meningitis is the term given to an inflammation of the membranes around the brain and spinal cord. The presence of bacteria in the blood is called meningococcemia. Pneumococcal meningitis mainly attacks younger children but can affect older children, too.

Another type of bacterial meningitis, Haemophilis influenzae type b disease, has been nearly wiped out since infant vaccine programs against HIb began in the mid-1980s.

Viral meningitis, another form, is not typically as deadly or debilitating as bacterial meningitis, and those stricken usually recover on their own.

Teens and young adults make up nearly 30 percent of all U.S. cases of bacterial meningitis, the CDC estimates.

The good news: Up to 83 percent of these cases among teens are thought to be preventable by vaccination, according to estimates from the National Meningitis Association.

Two vaccines are currently available in the United States. "Menomune was on the market first," explained Cary of Sanofi Pasteur. Next came Menactra, available since 2005.

Menactra is the vaccine typically given for routine vaccinations, Cary said, while Menomune would be given if an outbreak of meningitis occurred.

The vaccines cost about $90 to $120 and are typically paid for by insurance plans or covered by childhood vaccine programs, Bozof said.

Menactra protects against four of the most common strains of meningococcal disease, Cary said, including strains A, C, Y and W135. It doesn't protect against strain B, but "no vaccine is available that does [that]," she said.

Preventing the disease is much preferred to treating it, the experts say, but they warn that even those who are vaccinated can still get the disease, as no vaccine is perfect. Teens and young adults in particular should know the symptoms, which are flu-like in the beginning and include nausea, vomiting, headache and fever, along with a stiff neck.

Immediate medical care is crucial. Antibiotics are given, and early treatment is important. Still, it does not guarantee a full recovery.

More information

To learn more about meningitis, visit the National Meningitis Association.

SOURCES: Donna Cary, spokeswoman, Sanofi Pasteur Inc., Swiftwater, Penn.; Lynn Bozof, executive director, National Meningitis Association, Marietta, Ga.

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Meningitis C vaccine a cost-effective success
2. Cure for Bacterial Meningitis
3. Efficacy Of Meningitis C Vaccine
4. Meningitis is rocking the capital again
5. New warning signs for child meningitis
6. Uganda Tackles The Meningitis Outbreak
7. Fatal Case of Meningitis Detected In Massachusetts
8. Meningitis Back in Delhi and 21 Dead
9. New Delhi Hit By Meningitis Deaths
10. Cost-effective Meningitis Vaccine To Be Launched In Africa
11. Delhi Witnessed 34 Meningitis Deaths In Three Months
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology: